Valeant Pharmaceuticals International headquarters in Laval, Quebec. Photo: Reuters

US asset buying binge intensifies as Sanpower snaps up prostate cancer drug maker

Asset-hungry conglomerate inks deal for biotechnology pioneer and maker of Provenge amid concerns that Washington will move against hi-tech acquisitions

Topic |   Mergers & Acquisitions

TOP PICKS

Valeant Pharmaceuticals International headquarters in Laval, Quebec. Photo: Reuters
READ FULL ARTICLE